Medical Australia Limited
www.bmdituta.com/IRM/content/home.htmlProfil
Medical Australia Limited, formerly BMDi TUTA, is an Australia-based company. The Company is engaged in development, manufacture and distribution of, a range of medical devices. The Company focuses on five clinical therapy areas within the broader medical devices market – intravenous (IV) systems; safety (injection, collection, destruction); blood banking; surgical products and anaesthesia products. The Company’s subsidiaries include BMDI Pty Ltd., BMDI TUTA Healthcare Pty Ltd, Bio Medical Developments International Pty Ltd., IMD Consulting Pty Ltd. and International Water Systems Pty Ltd.
Aktienkurs
Vorstellungen
Keine Unterlagen verfügbar.
Verbundene Recherche
Keine Unterlagen verfügbar.
Unternehmensstrategie und – daten:
Mission & strategy
Platmin’s mission is to explore, develop and operate PGMs and associated base metals mining operations with key partners in a sustainable way, by complying to safety, health and environmental practices within the ambit of our social responsibilities.
Key strengths
Platmin’s strength lies in the combination of its quality project, management skills, partnerships and ability to finance its projects to explore and develop platinum group metals (PGMs) mineral resources located in the world’s largest PGM district.
The market for PGMs is strong and growing, particularly for use in autocatalysts and, in the longer term, for clean-energy products such as fuel cells. Demand for platinum and rhodium, in autocatalysts accounted for approximately 61% of total demand in 2007 (ref Johnson & Matthey 2007). Demand for PGMs in jewellery is firm, particularly in fast-growing eastern economies.
Platmin is led by a highly experienced management team and board of directors including professional geologists, engineers and financiers and metallurgists, with relevant PGM exploration, development and operating experience. It has Joint Venture agreements and business relationships with several major PGM producers including Anglo Platinum on the Pilanesberg Project area, Lonmin Plc on the Loskop Project and BHP Billiton and Samancor Chrome on the Grootboom Project. (
Read More
)
Aktuelle Tätigkeiten:
Platmin's projects
Platmin’s four key projects – Pilanesberg, Mphahlele, Grootboom and Loskop – are located on the Bushveld Complex of South Africa, a geological structure that is estimated to contain approximately 90% of the world’s platinum resources as well as some 80% of its chrome.
A feasibility study has been completed (SRK Consulting – announced July 2007) for the Pilanesberg Project and engineers appointed (Dowding Reynard & Associates) to design and build facilities to mine and process ore from the two open pits. Exploration, Mineral Resource delineation and feasibility work is being progressed on the other key projects.
For further details on Platmin's projects click HERE
Management
BOARD OF DIRECTORS
For more information click HERE
Rupert Pardoe - Chairman
BA(Hons)
Kwape Mmela - Chief Strategic Officer
Keith Liddell - Deputy Chairman
BSc Hons (Minerals Engineering); MSc (Engineering)
Ian Clyde Watson - Chief Executive Officer
Pr Eng
Ronald Little - Director
BSc Pr Eng
Dr Peter Ruxton - Director
BSc (Hons); PhD Economic Geology; MBA
Jay Kellerman - Director
B Laws
Hauptaktionäre
Shareholder information as at 31 August 2008
Symbol TSX/AIM: PPN
Capital Stock:
* Common Shares – 111,586,762
Significant Shareholdings
|
|
|
---|---|---|
Name of
entity Lonmin plc |
Number of
23,332,520 |
Percentage of outstanding
20.91% |
Mineral Securities Ltd | 19,546,674 | 17.52% |
Karrick Trust (Mittal) | 19,254,331 | 17.26% |
CDC Group plc | 14,396,909 | 12.90% |
Options
|
|
---|---|
Number outstanding: |
Options 4,791,900 |
Exercise price (approx): | US$ 1.20 – 10.11 |
Cash on dilution: | US$ 27 million |
Expiry: | 2008 – 2013 |
Financing information
Long term debt: US$ nil
Funds available: US$ 61,5 million
Kontakt
Registered Office:
290 Picton Street
Suite 201
Ottawa, Ontario
K1Z 8P8
Mailing address:
Private Bag x11
Highveld, 0067
South Africa
Company secretary:
Ralf Degni
Tel: +27 12 661 4280
[email protected]
Unternehmensinformationen
Nominated adviser
Grant Thornton Corporate Finance (Nomad)
Grant Thornton House
Melton Street
Euston Square
London NW1 2EP
United Kingdom